| COMPANY |
Alto Neuroscience, Inc. |
| COURT |
United States District Court for the Northern District of California |
| CASE NUMBER |
3:25-cv-06105 |
| JUDGE |
The Hon. Noel Wise |
| CLASS PERIOD |
1) common stock pursuant and/or traceable to IPO on or about February 2, 2024 and/or 2) securities between February 2, 2024 and October 22, 2024 |
| SECURITY TYPE |
Common Stock and Securities |
LEAD PLAINTIFF DEADLINE IS SEPTEMBER 19, 2025.
If you have suffered losses and would like to discuss your rights, please fill out this form or you may contact Jonathan Naji, Esq. at (484) 270-1453 or via e-mail at info@ktmc.com.
Case Background:
A class action lawsuit was filed on behalf of those who purchased or otherwise acquired Alto Neurosciences, Inc., (“Alto”) (NASDAQ: ANRO) (1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “IPO Documents”) issued in connection with Alto’s initial public offering on or about February 2, 2024; and/or (2) securities between February 2, 2024, and October 22, 2024, inclusive (the “Class Period”).
The complaint alleges that, in the IPO Documents and throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) its’ offering documents were negligently prepared; (2) ALTO-100, Alto’s drug that was in a Phase 2b clinical trial at the time of IPO, was less effective in treating major depressive disorder than investors were led to believe; (3) clinical, regulatory, and commercial prospects were overstated in regards to ALTO-100; and (4) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
What is a Lead Plaintiff?
A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. Filling out the online form above or communicating with any counsel is not necessary to participate or share in any recovery achieved in this case. Any member of the purported class may move the court to serve as a lead plaintiff through counsel of his/her choice, or may choose to do nothing and remain an inactive class member.